DRUG NEWS: Obesity, diabetes linked to drug therapy

$3.95
Nursing2014
April 2004 
Volume 34  Number 4
Pages 10 - 10
 
  PDF Version Available!

ABSTRACT
Outline

  • Source

    Health care professionals should carefully monitor people who take certain antipsychotic drugs for development of diabetes, obesity, and dyslipidemia. Participating in a consensus conference, experts from four organizations, including the American Diabetes Association (ADA), evaluated recent studies that link second-generation antipsychotic drugs with metabolic disorders. They found that clozapine (Clozaril) and olanzapine (Zyprexa) are more closely associated with weight gain, diabetes, and dyslipidemia than risperidone (Risperdal) or quetiapine (Seroquel). Aripiprozole (Abilify) and ziprasidone (Geodon) weren't associated with these disorders, but they haven't been as widely used as other drugs in this category.

    The experts ask health care professionals to screen for obesity, diabetes, dyslipidemia, and high blood pressure before prescribing an antipsychotic drug and to closely monitor the patient's response to treatment. ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!


Cost:$3.95
1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Password


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.


Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.






jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events